Fuji Pharma Co., Ltd.
4554
Rank in Stocks
#14635
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally,... Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
Share Price
$11.93
Last synced: 2026-11-10
Market Cap
$311.65M
Change (1 day)
2.72%
Change (1 year)
11.74%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fuji Pharma Co., Ltd. (4554)
Category
Healthcare
Operating Margin for Fuji Pharma Co., Ltd. (4554)
Operating Margin as of November 2026 TTM: 11.67%
According to Fuji Pharma Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 11.67%. At the end of 2025 the company had an operating margin of 9.66%.
Operating Margin history for Fuji Pharma Co., Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 11.67% | 20.81% |
| 2025 | 9.66% | 14.86% |
| 2024 | 8.41% | -10.91% |
| 2023 | 9.44% | -11.44% |
| 2022 | 10.66% | 8.22% |
| 2021 | 9.85% | 6.03% |
| 2020 | 9.29% | -19.22% |
| 2019 | 11.50% | -0.69% |
| 2018 | 11.58% | -5.00% |
| 2017 | 12.19% | 16.99% |
| 2016 | 10.42% | 1.56% |
| 2015 | 10.26% | -5.52% |
| 2014 | 10.86% | -16.14% |
| 2013 | 12.95% | -20.26% |
| 2012 | 16.24% | -19.08% |
| 2011 | 20.07% | 0.45% |
| 2010 | 19.98% | 10.14% |
| 2009 | 18.14% | 0.78% |
| 2008 | 18.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.34% |
DE
|
|
| 19.68% | -98.31% |
DE
|
|
| 13.26% | -98.86% |
JP
|
|
| 17.08% | -98.54% |
CH
|
|
| 14.92% | -98.72% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Fuji Pharma Co., Ltd.'s operating margin
What is Fuji Pharma Co., Ltd.'s operating margin?
Fuji Pharma Co., Ltd.'s operating margin is 11.67%, as of Nov 2026.
What was Fuji Pharma Co., Ltd.'s operating margin in 2025?
In 2025, Fuji Pharma Co., Ltd.'s operating margin was 9.66%, compared with 8.41% in 2024.
How has Fuji Pharma Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Fuji Pharma Co., Ltd.'s operating margin was highest in 2022 (10.66%) and lowest in 2024 (8.41%).
How does Fuji Pharma Co., Ltd.'s operating margin compare with similar companies?
Fuji Pharma Co., Ltd.'s operating margin (11.67%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.